Alterations of transforming growth factor B receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomas

Oncology Reports

Volumn 11, Issue 1, 2004, Pages 231-236

  Bhattacharyya, Nandan ^a   Tao, Jianming ^a   Klein, Eric A ^b   Banerjee, Sipra ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

IGRII; Microsatellites; Prostate carcinomas; TGFBRII

Indexed keywords

DNA; MICROSATELLITE DNA; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; CHEMISTRY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROSTATE TUMOR;

BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MUTAGENESIS, INSERTIONAL; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEQUENCE DELETION;

EID: 3543067054     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.1.231     Document Type: Article

References (27)

1. Loeb LA: Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059-5063, 1994.
2. Patel U, Chen HC and Banerjee S: Dinucleotide repeat polymorphisms at nine loci in sporadic colorectal cancer. Cell Mol Biol Res 40: 683-691, 1994.
3. Patel U, Grundfest-Broniatowski S, Gupta M and Banerjee S: Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene 9: 3695-3700, 1994. (Pubitemid 24359409)
4. Uchida T, Wada C, Wang C, Ishida H, Egawa S, Yokoyama E, Ohtani H and Koshiba K: Microsatellite instability in prostate cancer. Oncogene 2: 1019-1022, 1995.
5. Paulson TG, Wright FA, Parker BA, Russack V and Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021-4026, 1996. (Pubitemid 26284754)
6. Imai Y, Tsurutani N, Oda H, Inoue T and Ishikawa T: Genetic instability and mutation of the TGF-beta-receptor-II gene in ampullary carcinomas. Int J Cancer 76: 407-411, 1998. (Pubitemid 28282941)
7. Moses HL, Yang EY and Pietenpol JA: TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247, 1990.
8. Sporn MB and Roberts AB: TGF-beta: problems and prospects. Cell Regul 1:875-882, 1990.
9. Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J, Papadopolous N, Peltomäki P, De la Chapelle A, Hamilton SR, et al: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9: 48-55, 1995.
10. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park, K, et al: A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547, 1995.
11. Massague J: The transforming growth factor-beta family. Annu Rev Cell Biol 6: 597-641, 1990.
12. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA and Lodish HF: Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775-785, 1992.
13. Yan Z, Winawer S and Friedman E: Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells. J Biol Chem 269: 13231-13237, 1994. (Pubitemid 24206089)
14. Hsu S, Huang F, Hafez M, Winawer S and Friedman E: Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. Cell Growth Differ 5: 267-275, 1994. (Pubitemid 24251376)
15. Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Wilson JKV and Brattain MG: Demonstration that mutation of type II TGFb recptor inactivates it tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 220: 22044-22049, 1997.
16. Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK and Markowitz S: Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 59: 320-324, 1999. (Pubitemid 29048861)
17. Purchio AF, Cooper JA, Brunner AM, Lioubin MN, Gentry LE, Kovacina KS, Roth R A and Marquardt H: Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta 1 precursor. J Biol Chem 263: 14211-14215, 1988.
18. Kojima S, Nara K and Rifkin DB: Requirement for transglutaminase in the activation of latent transforming growth factorbeta in bovine endothelial cells. J Cell Biol 121: 439-448, 1993. (Pubitemid 23110886)
19. Dennis PA and Rifkin DB: Cellular activation of latent transforming growth factor beta requires binding to the cationindependent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88: 580-584, 1991. (Pubitemid 21915509)
20. Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME and Cullen KJ: Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10: 286-297, 1996. (Pubitemid 26082700)
21. Souza RF, Wang S, Thakar M, Smolinski KN, Yin J, Zou TT, Kong D, Abraham JM, Toretsky JA and Meltzer SJ: Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene 18: 4063-4068, 1999. (Pubitemid 29363913)
22. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
23. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B: Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550, 1995.
24. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998.
25. Perucho M: Correspondence re: C. R. Boland et at A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5428-5257, 1998. Cancer Res 59: 249-253, 1999.
26. Kingsley DM: The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133-146, 1994.
27. Thompson TC: Growth factors and oncogenes in prostate cancer. Cancer Cells 2: 345-354, 1990.